Significance of autotaxin activity and overexpression in comparison to soluble intercellular adhesion molecule in thyroid cancer

International Journal of Biological Markers

Volumn 28, Issue 1, 2013, Pages 84-91

  Hassan, Azza M ^a   Alm El Din, Mohamed A ^a   Nagy, Hala ^a   Ghoneem, Naglaa ^a   El Heniedy, Mohamed A ^a   Koteb, Nessreen ^a   El Gohary, Salah ^a  

^a TANTA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

Activity; Autotaxin; Overexpression; Thyroid cancer

Indexed keywords

AUTOTAXIN; COMPLEMENTARY DNA; GENOMIC DNA; INTERCELLULAR ADHESION MOLECULE 1;

ADENOMA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SWELLING; THYROID CARCINOMA; TUMOR VOLUME; ULTRASOUND;

ADENOMA; CARCINOMA, PAPILLARY; GENE EXPRESSION; GOITER; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHATIC METASTASIS; PHOSPHORIC DIESTER HYDROLASES; THYROID NEOPLASMS; TUMOR BURDEN;

EID: 84876713419     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/JBM.2013.10780     Document Type: Article

References (45)

1. American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society, 2007.
2. Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 2002; 235: 656-54.
3. Hamberger B, Gharib H, Melton LJ 3rd, Goellner JR, Zinsmeister AR. Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med 1982; 73: 381-384.
4. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002; 26: 41-44.
5. Bryson PC, Shores CG, Hart C, et al. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. Arch Otolaryngol Head Neck Surg 2008; 134: 581-586.
6. Abdelrazik N, Fouda M, Zaghloul MH, Abbas D. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma. Med Princ Pract 2008; 17: 233-8.
7. Benson V, McMahon AC, Lowe HC. ICAM-1 in acute myocardial infarction: a potential therapeutic target. Curr Mol Med 2007; 7: 219-227.
8. Brake DK, Smith EO, Mersmann H, Smith CW, Robker RL. ICAM-1 expression in adipose tissue: effects of dietinduced obesity in mice. Am J Physiol Cell Physiol 2006; 291: C1232-C1239.
9. Covarrubias M, Ware LB, Kawut SM, et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573-2578.
10. El-Gohary AM, Fawaz NA, Hassoba HM, Serwah A, Ali M. Soluble ICAM-1 in patients with chronic hepatitis C infection: a prognostic marker of disease activity. Egypt J Immunol 2004; 11: 109-119.
11. Gaetano CG, Samadi N, Tomsig JL, Macdonald TL, Lynch KR, Brindley DN. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. Mol Carcinog 2009; 48: 801-809.
12. Clair T, Lee HY, Liotta LA, Stracke ML. Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem 1997; 272: 996-1001.
13. Stracke ML, Krutzsch HC, Unsworth EJ, et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 1992; 267: 2524-2529.
14. Umezu-Goto M, Kishi Y, Taira A, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002; 158: 227-233.
15. Dennis J, Nogaroli L, Fuss B. Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease. J Neurosci Res 2005; 82: 737-742.
16. Clair T, Aoki J, Koh E, et al. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 2003; 63: 5446-5453.
17. Hooks SB, Santos WL, Im DS, Heise CE, Macdonald TL, Lynch KR. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent. J Biol Chem 2001; 276: 4611-4621.
18. McIntyre TM, Pontsler AV, Silva AR, et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci U S A 2003; 100: 131-136.
19. Liu S, Murph M, Panupinthu N, Mills GB. ATX-LPA receptor axis in inflammation and cancer. Cell Cycle 2009; 8: 3695-3701.
20. Kehlen A, Englert N, Seifert A, et al. Expression, regulation and function of autotaxin in thyroid carcinomas. Int J Cancer 2004; 109: 833-838.
21. American Joint Committee on Cancer. Thyroid. In: AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer, 2010; 87-92.
22. Sajdok J, Jandus J, Valentova O, Novotna Z, Kas J, Daussant J. A microplate technique for phospholipase D activity determination. Analytica Chimica Acta 1995; 315: 109-112.
23. Seifert A, Klonisch T, Wulfaenger J, et al. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells. Oncol Rep 2008; 19: 1485-1491.
24. Gaetano CG, Samadi N, Tomsig JL, Macdonald TL, Lynch KR, Brindley DN. Inhibition of autotaxin production or activity block lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. Mol Carcinog 2009; 48: 801-809.
25. Hama K, Aoki J, Fukaya M, et al. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 2004; 279: 17634-17639.
26. Umezu-Goto M, Tanyi J, Lahad J, et al. Lysophosphatidic acid production and action: validated targets in cancer? J Cell Biochem 2004; 92: 1115-1140.
27. Nam SW, Clair T, Kim YS, et al. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 2001; 61: 6938-6944.
28. Chevillard S, Ugolin N, Vielh P, et al. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res 2004; 10: 6586-6597.
29. Frisk T, Kytola S, Wallin G, Zedenius J, Larsson C. Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 25: 349-353.
30. Hoos A, Stojadinovic A, Singh B, et al. Clinical significance of molecular expression profiles of Hurthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am J Pathol 2002; 160: 175-183.
31. Rodrigues-Serpa A, Catarino A, Soares J. Loss of heterozygosity in follicular and papillary thyroid carcinomas. Cancer Genet Cytogenet 2003; 141: 26-31.
32. Grimm D, Bauer J, Kossmehl P, et al. Simulated microgravity alters differentiation and increases apoptosis in human follicular thyroid carcinoma cells. FASEB J 2002; 16: 604-606.
33. Tanda F, Cossu A, Bosincu L, Manca A, Ibba M, Massarelli G. Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas. Mod Pathol 1996; 9: 53-56.
34. Pasieka Z, Kuzdak K, Czyz W, Stepien H, Komorowski J. Soluble intracellular adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood of patients with thyroid cancer. Neoplasma 2004; 51: 34-37.
35. Pasieka Z, Stepien H, Komorowski J, Kolomecki K, Kuzdak K. Evaluation of the levels of bFGF, VEGF, sICAM-1, and sVCAM-1 in serum of patients with thyroid cancer. Recent Results Cancer Res 2003; 162: 189-194.
36. Fernández-Real JM, Villabona C, Fernández-Castañer M, Sagarra E, Gómez-Sáez JM, Soler J. Expression of ICAM-1 in distant metastatic thyroid carcinoma. J Endocrinol Invest 1996; 19: 183-185.
37. Nakashima M, Eguchi K, Ishikawa N, et al. Expression of adhesion molecule ICAM-1 (CD54) in thyroid papillary adenocarcinoma. J Endocrinol Invest 1994; 17: 843-848.
38. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci U S A 1989; 86: 641-644.
39. Koyama S, Ebihara T, Fukao K. Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma. J Cancer Res Clin Oncol 1992; 118: 609-614.
40. Tempia-Caliera AA, Horvath LZ, Zimmermann A, et al. Adhesion molecules in human pancreatic cancer. J Surg Oncol 2002; 79: 93-100.
41. Sawada T, Kimura K, Nishihara T, et al. TGF-beta1 downregulates ICAM-1 expression and enhances liver metastasis of pancreatic cancer. Adv Med Sci 2006; 51: 60-65.
42. Arnold JM, Cummings M, Purdie D, Chenevix-Trench G. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer 2001; 85: 1351-8.
43. Tanaka H, Yashiro M, Sunami T, Ohira M, Hirakawa K, Chung YS. Lipid-mediated gene transfection of intercellular adhesion molecule-1 suppresses the peritoneal metastasis of gastric carcinoma. Int J Mol Med 2002; 10: 613-617.
44. Chai YC, Howe PH, DiCorleto PE, Chisolm GM. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem 1996; 271: 17791-17797.
45. Hirata K, Miki N, Kuroda Y, Sakoda T, Kawashima S, Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res 1995; 76: 958-962.